Gapping up
In reaction to earnings/guidance:
- CROX +9.4%, XM +6.1%, TDAC +4.7%, THC +4.4%, HPQ +4.3% (reaffirms FY21 EPS guidance; issues upside FY22 EPS guidance; raises annual dividend 29% to $1/sh), CSX +4%, DGX +4%, SASR +3.3%, TRN +3.3%, SLM +3.1% (also approves $250 mln increase to share repurchase program and increases dividend), BX +2.5%, TSCO +2.3%, SAP +2.1%, TPH +2%, UL +1.8%, DOW +1.8%, AN +1.7%, T +1.5%, FAF +1.3%, EFX +1.2%, AAL +1.2%, MMC +0.9%, FR +0.8%, DHR +0.8%
Other news:
- TSC +26.5% (TSC to be acquired by RJF in cash and stock deal worth $1.1 bln)
- SIOX +17.2% (Interim Safety and Biomarker Data from Ongoing Phase 1/2 Clinical Study of AXO-AAV-GM1)
- CRNX +4.8% (stock offering)
- ONEW +3% (to acquire T-H Marine for approx. $185 mln)
- BNTX +2.1% (BioNTech and Pfizer (PFE) announces topline results from a Phase 3 randomized controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10000 individuals 16 years of age and older)
- MRNA +0.9% (FDA approves booster dose for JNJ and Moderna vaccines and allows for mixing and matching)
- PFE +0.8% (CDC advisory committee votes to recommend routine use of PREVNAR 20 in adults)
- UNIT +0.8% (Zayo Group seeking to acquire UNIT according to WSJ)
- MYRG +0.8% (signs contract with a renewable energy developer for large scale solar project in CA)
- CNI +0.7% (Elliot Mgmt has a big stake according to WSJ)
Analyst comments:
- DENN +3.1% (upgraded to Buy from Hold at Truist)
- ARMK +1.5% (upgraded to Buy from Hold at Berenberg)
- CTRA +1.5% (upgraded to Overweight from Neutral at Piper Sandler)